Barbara Mroczkowski

3.9k total citations · 2 hit papers
24 papers, 2.4k citations indexed

About

Barbara Mroczkowski is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Barbara Mroczkowski has authored 24 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Genetics. Recurrent topics in Barbara Mroczkowski's work include Glycosylation and Glycoproteins Research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and RNA Research and Splicing (3 papers). Barbara Mroczkowski is often cited by papers focused on Glycosylation and Glycoproteins Research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and RNA Research and Splicing (3 papers). Barbara Mroczkowski collaborates with scholars based in United States, United Kingdom and Malaysia. Barbara Mroczkowski's co-authors include Gerrit Los, Gordon Alton, James G. Christensen, Qiuhua Li, Helen Y. Zou, Shinji Yamazaki, Joseph H. Lee, Scott R. McDonnell, Maria E. Arango and Stanley Cohen and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Barbara Mroczkowski

24 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms

2007 593 citations Helen Y. Zou, Qiuhua Li et al. Cancer Research profile →
Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma

2007 513 citations James G. Christensen, Helen Y. Zou et al. Molecular Cancer Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbara Mroczkowski United States	18	1.5k	850	662	238	228	24	2.4k
Jennifer L. Stamos United States	14	2.2k 1.5×	788 0.9×	370 0.6×	260 1.1×	195 0.9×	17	3.3k
Richard Kendall United States	24	1.8k 1.2×	837 1.0×	268 0.4×	236 1.0×	238 1.0×	43	3.0k
Terence O’Reilly Switzerland	24	2.0k 1.3×	1.1k 1.3×	668 1.0×	354 1.5×	253 1.1×	36	3.2k
Volker Wacheck Austria	35	2.3k 1.5×	1.0k 1.2×	480 0.7×	172 0.7×	326 1.4×	113	3.6k
Kyle D. Holen United States	31	1.1k 0.8×	1.8k 2.1×	479 0.7×	312 1.3×	232 1.0×	126	3.2k
Alan Huang United States	24	2.3k 1.5×	1.3k 1.5×	917 1.4×	198 0.8×	327 1.4×	64	3.3k
Mogens Spang‐Thomsen Denmark	30	1.6k 1.0×	1.4k 1.7×	439 0.7×	150 0.6×	292 1.3×	96	3.0k
Mikkel W. Pedersen Denmark	25	1.0k 0.7×	1.2k 1.4×	484 0.7×	156 0.7×	185 0.8×	54	2.3k
J Mattern Germany	30	1.7k 1.1×	1.5k 1.8×	520 0.8×	160 0.7×	153 0.7×	140	3.4k
Carol Waghorne Canada	16	1.3k 0.9×	528 0.6×	268 0.4×	279 1.2×	124 0.5×	29	2.1k

Countries citing papers authored by Barbara Mroczkowski

Since Specialization

Citations

This map shows the geographic impact of Barbara Mroczkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Mroczkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Mroczkowski more than expected).

Fields of papers citing papers by Barbara Mroczkowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Mroczkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Mroczkowski. The network helps show where Barbara Mroczkowski may publish in the future.

Co-authorship network of co-authors of Barbara Mroczkowski

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Mroczkowski. A scholar is included among the top collaborators of Barbara Mroczkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Mroczkowski. Barbara Mroczkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Feng, Shan Li, William M. Rosencrans, et al.. (2022). Sulforaphane is Synergistic with CB‐5083 and Inhibits Colony Formation of CB‐5083‐Resistant HCT116 Cells. ChemMedChem. 17(11). e202200030–e202200030. 7 indexed citations

LeBlanc, Amy K., Christina Mazcko, Timothy M. Fan, et al.. (2022). Comparative Oncology Assessment of a Novel Inhibitor of Valosin-Containing Protein in Tumor-Bearing Dogs. Molecular Cancer Therapeutics. 21(10). 1510–1523. 6 indexed citations

Banerjee, Soojay, Alberto Bartesaghi, Alan Merk, et al.. (2016). 2.3 Å resolution cryo-EM structure of human p97 and mechanism of allosteric inhibition. Science. 351(6275). 871–875. 269 indexed citations

Guo, Chuangxing, Xinjun Hou, Liming Dong, et al.. (2009). Structure-based design of novel human Pin1 inhibitors (I). Bioorganic & Medicinal Chemistry Letters. 19(19). 5613–5616. 91 indexed citations

Kummar, Shivaani, Larry Rubinstein, Robert J. Kinders, et al.. (2008). Phase 0 Clinical Trials: Conceptions and Misconceptions. The Cancer Journal. 14(3). 133–137. 68 indexed citations

Zou, Helen Y., Qiuhua Li, Joseph H. Lee, et al.. (2007). An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms. Cancer Research. 67(9). 4408–4417. 593 indexed citations breakdown →

Christensen, James G., Helen Y. Zou, Maria E. Arango, et al.. (2007). Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma. Molecular Cancer Therapeutics. 6(12). 3314–3322. 513 indexed citations breakdown →

Zhu, Jeff, Eleanor Dagostino, Paul A. Rejto, Barbara Mroczkowski, & Brion W. Murray. (2007). Identification and characterization of a novel and functional murine Pin1 isoform. Biochemical and Biophysical Research Communications. 359(3). 529–535. 9 indexed citations

Kung, Pei‐Pei, et al.. (2007). Structure activity relationships of quinoline-containing c-Met inhibitors. European Journal of Medicinal Chemistry. 43(6). 1321–1329. 17 indexed citations

10.

McTigue, Michele, John Wickersham, Richard E. Showalter, et al.. (1999). Crystal structure of the kinase domain of human vascular endothelial growth factor receptor 2: a key enzyme in angiogenesis. Structure. 7(3). 319–330. 161 indexed citations

11.

Krahl, Troy, et al.. (1999). Transgenic expression of epidermal growth factor and keratinocyte growth factor in beta-cells results in substantial morphological changes. Journal of Endocrinology. 162(2). 167–175. 48 indexed citations

12.

Mroczkowski, Barbara, et al.. (1994). Secretion of thermostable DNA polymerase using a novel baculovirus vector.. Journal of Biological Chemistry. 269(18). 13522–13528. 26 indexed citations

13.

Rousseau, Dennis L., Cheryl A. Guyer, Albert H. Beth, et al.. (1993). Preparation and characterization of a bifunctionally spin-labeled mutant of murine epidermal growth factor for saturation-transfer electron paramagnetic resonance studies of the growth factor/receptor complex. Biochemistry. 32(31). 7893–7903. 7 indexed citations

14.

Mroczkowski, Barbara. (1991). Expression of epidermal growth factor precursor cDNA in animal cells. Methods in enzymology on CD-ROM/Methods in enzymology. 198. 175–185. 1 indexed citations

15.

Mroczkowski, Barbara, Martha B. Reich, Katherine Chen, Graeme I. Bell, & Stanley Cohen. (1989). Recombinant Human Epidermal Growth Factor Precursor Is a Glycosylated Membrane Protein with Biological Activity. Molecular and Cellular Biology. 9(7). 2771–2778. 93 indexed citations

16.

Mroczkowski, Barbara, et al.. (1988). Differentiation of HL‐60 cells is associated with an increase in the 35‐kDa protein lipocortin I. Journal of Cellular Physiology. 137(3). 402–410. 50 indexed citations

17.

Mroczkowski, Barbara, Martha B. Reich, J. R. Whittaker, Graeme I. Bell, & Stanley Cohen. (1988). Expression of human epidermal growth factor precursor cDNA in transfected mouse NIH 3T3 cells.. Proceedings of the National Academy of Sciences. 85(1). 126–130. 31 indexed citations

18.

De, Barun K., K S Misono, T. J. Lukas, Barbara Mroczkowski, & Stanley Cohen. (1986). A calcium-dependent 35-kilodalton substrate for epidermal growth factor receptor/kinase isolated from normal tissue.. Journal of Biological Chemistry. 261(29). 13784–13792. 183 indexed citations

19.

Mroczkowski, Barbara, Gisela Mosig, & Stanley Cohen. (1984). ATP-stimulated interaction between epidermal growth factor receptor and supercoiled DNA. Nature. 309(5965). 270–273. 45 indexed citations

20.

McCarthy, Thomas L., et al.. (1983). Characterization of translational-control ribonucleic acid isolated from embryonic chick muscle. Biochemistry. 22(4). 935–941. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact